Compare Aether Industri. with Similar Stocks
Dashboard
Company has a Debt to Equity ratio (avg) of 0.02 times
Healthy long term growth as Net Sales has grown by an annual rate of 21.16% and Operating profit at 26.18%
With a growth in Net Profit of 19.5%, the company declared Outstanding results in Dec 25
Increasing Participation by Institutional Investors
Market Beating Performance
Stock DNA
Specialty Chemicals
INR 16,264 Cr (Small Cap)
73.00
42
0.00%
0.07
8.71%
6.95
Total Returns (Price + Dividend) 
Aether Industri. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Broad-Based Technical Strength Lifts Aether Industries Ltd to 52-Week High of Rs 1274.2
Surging past its previous peaks, Aether Industries Ltd reached a fresh 52-week high of Rs 1274.2 on 4 May 2026, propelled by a confluence of robust technical indicators and sustained price momentum that has captivated market attention.
Read full news article
Aether Industries Ltd Surges 7.9% to Day's High of Rs 1259.15 — Outperforms Sector by 6.16 Percentage Points
The Sensex advanced 0.82% on 4 May 2026, yet Aether Industries Ltd outpaced the broader market with a robust 7.9% gain, reaching an intraday high of Rs 1259.15. This 6.16 percentage-point outperformance over its Specialty Chemicals sector peers signals a distinctly stock-specific momentum rather than a mere market lift.
Read full news article
Aether Industries Ltd Hits All-Time High of Rs 1,252 as Momentum Builds Across Timeframes
Extending its recent rally, Aether Industries Ltd surged 6.75% on 4 May 2026 to close at a fresh all-time high of Rs 1,252, outpacing the Sensex which gained just 0.97% on the day. This move marks a continuation of a strong upward trend that has seen the stock outperform its sector and broader market indices over multiple timeframes.
Read full news article Announcements 
Intimation For The Receipt Of Demand And Show Cause Notice
24-Apr-2026 | Source : BSEIn accordance with Reg. 30 of the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015 we herewith annex the intimation for the receipt of Demand and Show Cause Notice from the CGST & Central Excise Commissionerate Surat as annexed.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
04-Apr-2026 | Source : BSEIn accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended from time to time we herewith submit the schedule of Investor Meetings with Company Officials at in Mumbai as annexed.
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
27-Mar-2026 | Source : BSEIn accordance with Reg. 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we herewith inform about allotment of 5454 equity shares upon exercise of stock options as per AIL ESOS 2021 as annexed.
Corporate Actions 
15 May 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 15 Schemes (11.58%)
Held by 84 FIIs (6.29%)
Purnima Ashwin Desai (17.4%)
Sbi Multicap Fund (8.63%)
4.88%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 13.22% vs 9.35% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 19.50% vs 14.76% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 40.24% vs 16.46% in Sep 2024
Growth in half year ended Sep 2025 is 56.00% vs -2.65% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 41.75% vs 24.52% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 53.03% vs 28.84% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 40.21% vs -8.13% in Mar 2024
YoY Growth in year ended Mar 2025 is 92.05% vs -36.75% in Mar 2024






